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alterations of phospholipid composition in the spinal cord
of an amyotrophic lateral sclerosis (ALS) mouse model
(G93A-mutated human superoxide dismutase 1 transgenic
mice [SOD1G93A mice]) using imaging mass spectrometry
(IMS), a powerful method to visualize spatial distributions
of various types of molecules in situ. Using this technique,
we deciphered the phospholipid distribution in the pre-
symptomatic stage, early stage after disease onset, and
terminal stages of disease in female SOD1G93A mouse spinal
cords. These experiments revealed a signiﬁcant decrease in
levels of docosahexaenoic acid (DHA)-containing phos-
phatidylcholines (PCs), such as PC (diacyl-16:0/22:6), PC
(diacyl-18:0/22:6), and PC (diacyl-18:1/22:6) in the L5http://dx.doi.org/10.1016/j.neuroscience.2015.03.060
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127anterior horns of terminal stage (22-week-old) SOD1G93A
mice. The reduction in PC (diacyl-16:0/22:6) level could be
reﬂecting the loss of motor neurons themselves in the ante-
rior horn of the spinal cord in ALS model mice. In contrast,
other PCs, such as PC (diacyl-16:0/16:0), were observed
speciﬁcally in the L5 dorsal horn gray matter, and their
levels did not vary between ALS model mice and controls.
Thus, our study showed a signiﬁcant decrease in DHA-con-
taining PCs, but not other PCs, in the terminal stage of ALS
in model mice, which is likely to be a reﬂection of neuronal
loss in the anterior horns of the spinal cords. Given its
enrichment in dorsal sensory regions, the preservation of
PC (diacyl-16:0/16:0) may be the result of spinal sensory
neurons being unaﬀected in ALS. Taken together, these
ﬁndings suggest that ALS spinal cords show signiﬁcant
alterations in PC metabolism only at the terminal stage of
the disease, and that these changes are conﬁned to speciﬁc
anatomical regions and cell types.  2015 The
Authors. Published by Elsevier Ltd. on behalf of IBRO.
This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive, life-
threatening neurodegenerative disease caused by the
degeneration of upper and lower motor neurons in the
cortex, brain stem, and spinal cord (Rosen et al., 1993;
Bruijn et al., 1998; Clement et al., 2003). Approximately
90% of cases of ALS appear to be sporadic without a fam-
ily history of the disease. The remaining 10% of patients
are diagnosed with familial ALS (fALS), and approxi-
mately 20% of these familial cases are caused by domi-
nant mutations in Cu/Zn superoxide dismutase 1
(SOD1) (Bruijn et al., 1998; Clement et al., 2003; Di
Giorgio et al., 2007). A widely used transgenic mouse
model of fALS (SOD1G93A mice) has been developed
through the insertion of a G93A-mutated human SOD1
transgene into the murine genome (Gurney et al., 1994;
Bendotti and Carri, 2004; Takeuchi et al., 2011).
SOD1G93A mice show severe atrophy in the anterior horns
of the spinal cord characterized by marked neuronal loss
and activation of microglia and astrocytes, as is observed
in patients with ALS (Bendotti and Carri, 2004; Takeuchi
et al., 2011; Acquadro et al., 2014). However, the bio-
chemical and molecular pathogenesis of ALS remainsons.org/licenses/by-nc-nd/4.0/).
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yet been established for treating ALS (Hirano et al.,
2013).
The most abundant biomolecules in the central nerve
system, including the spinal cord, are lipids, which
function to facilitate vesicle fusion, regulate ion ﬂux, and
create specialized microenvironments that promote
cellular communication (Piomelli et al., 2007). Recently,
imaging mass spectrometry (IMS) has emerged as a
promising new technology that enables simultaneous
imaging of many types of biomolecules including lipids
(Hayasaka et al., 2008; Sugiura and Setou, 2010). This
technique thereby advances the ability to investigate
alterations in the distribution of the molecular components
of speciﬁc areas of the central nervous system in dis-
eases states, thus providing further insights into new
therapeutic targets for human pathologies (Wisztorski
et al., 2008; Acquadro et al., 2014). Using this technique,
we recently observed changes in lipid metabolism in the
spine following spinal cord injury (Hanada et al., 2012;
Arima et al., 2014). In addition, matrix-assisted laser des-
orption/ionization (MALDI)-IMS analysis of brain tissue
slices harvested from the central nervous system of dis-
ease model organisms is emerging as a powerful new
means to the study neurodegenerative disease (Yuki
et al., 2014). However, comprehensive studies of lipid
molecules in neurodegenerative disease states using
MALDI-MS are limited.
To date, two published studies utilized MALDI imaging
to study molecular properties of ALS in either patient-
derived specimens or animal models. An analysis of
human post-mortem spinal cord samples indicated that
two protein species, including a C-terminally truncated
form of ubiquitin, were decreased in ALS (Hanrieder
et al., 2013). The other study was carried out using
SOD1G93A mice and found that human SOD1G93A protein
was accumulated in the facial and trigeminal nuclei of
these mice (Acquadro et al., 2014). As is the case with
the majority of research into the neurobiological mecha-
nisms of ALS, both studies focused mainly on protein
alterations in the brain and spinal cord.
However, an increasing number of reports
demonstrate that there are important neurobiological
roles for neural lipids in health and disease (Piomelli
et al., 2007). In this study, we set out to characterize
alterations in the composition of phospholipids in ALS
using MALDI-IMS, which is eﬀective for detecting and
visualizing phospholipid metabolism (Jackson et al.,
2005, 2007; McLean et al., 2007; Hayasaka et al.,
2008). The major structural phospholipids in eukaryotic
membranes are the glycerophospholipids: phosphatidyl-
choline (PC), phosphatidylethanolamine, phos-
phatidylserine, phosphatidylinositol, and phosphatidic
acid. PCs account for >50% of the phospholipids in
most eukaryotic membranes (van Meer et al., 2008). In
this study, we therefore utilized IMS to investigate the
characteristics of the lipid composition in the SOD1G93A
ALS mouse model with a focus on PC molecular species
and assessed whether changes in the phospholipid com-
position were associated with disease progression and
pathogenesis.EXPERIMENTAL PROCEDURE
Chemicals
Methanol, potassium acetate, carboxymethyl cellulose
(CMC), and ultrapure water were purchased from Wako
Pure Chemical Industries (Osaka, Japan). Calibration-
standard peptides and 2,5-dihydroxybenzoic acid (DHB),
a MALDI matrix, were purchased from Bruker Daltonics
(Fremont, CA, USA). All chemicals used in this study
were of the highest purity available.Animals and survival analysis
All the experimental procedures were approved by the
Ethics Committee of the Hamamatsu University School
of Medicine (Shizuoka, Japan). Transgenic mice, which
carry a high copy number of a transgenic encoding a
G93A mutant of human SOD1 (B6.Cg-Tg [SOD1-
G93A]1Gur/J line) (Gurney et al., 1994), were purchased
from the Jackson Laboratory (Bar Harbor, ME, USA).
Oﬀspring hemizygous for the mutant SOD1 transgene
used in this study were produced by strict crossings of
hemizygous male B6.SOD1G93A mice with wild-type
C57BL/6 inbred females to maintain the mutant transgene
on a C57BL/6 congenic background (n> 10). Isolated
genomic blood DNA was used to genotype animals using
a standard protocol provided by the Jackson Laboratory,
as previously described (Hayworth and Gonzalez-Lima,
2009).
For image analysis, female SOD1G93A and non-
transgenic littermate mice at the age of 5 weeks (before
disease onset), 10 weeks (an early stage after disease
onset), and 22 weeks (a terminal stage after onset of
disease) were used (n= 3 for each time point). Body
weight was measured once a week (n= 4 for each
group). Food and water were provided ad libitum, and
animals were housed three/cage in a room with a 12-h
light/dark cycle. Animals with substantial motor
impairment had food provided on the cage bottom and
spouts of water bottles were set near the bottom of
the cage. We also investigated survival time in the
SOD1G93A group (n= 4 for each group). Survival time
was deﬁned as the age when the animals were unable
to move right themselves within 60 s of being placed on
either side of their body. At this point, the animals were
deeply anesthetized with ether and then sacriﬁced.Tissue preparation for IMS
Mice were anesthetized with 25 mg/kg pentobarbital
sodium and killed by transcardial perfusion with cold
0.01 M phosphate-buﬀered saline (PBS). Mouse spinal
cord specimens of approximately 2 cm in length
originating around the L5 level were extracted.
Segments of the spinal cord were embedded in CMC
compound and sliced using a cryostat at a thickness of
10 lm (CM1950; Leica, Wetzlar, Germany) along the
axial plane (SOD1G93A group: 5th week, n= 3; 10th
week, n= 3; 22nd week, n= 3; and control group; 5th
week, n= 3; 10th week, n= 3; 22nd week, n= 3).
Sections were then placed directly onto glass slides
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until matrix application and subsequent IMS.IMS sample preparation and IMS analysis
DHB solution (50 mg/mL DHB, 20 mM potassium acetate,
70% methanol) was used as the matrix solution to detect
signals of PC species. The matrix solution (approximately
500 lL) was sprayed over the tissue surface using a 0.2-
mm nozzle caliber airbrush (ProCon Boy FWA Platinum;
Mr. Hobby, Tokyo, Japan). Tissue sections were spray-
coated with the matrix solution in order to perform
extraction and co-crystallization simultaneously. The
distance between the nozzle tip and tissue surface was
maintained at 10 cm, and the spraying period was ﬁxed
at 20 min. IMS analyses were performed using a MALDI
time-of-ﬂight (TOF)/TOF-type instrument (ultraﬂex II
TOF/TOF; Bruker Daltonics) equipped with a 355-mm
Nd:YAG laser. Data were acquired in the positive
reﬂectron mode under an accelerating potential of 25 kV
using an external calibration method. Signals between
m/z 400 and 1000 were collected, and raster scans of
tissue surfaces were automatically obtained at a spatial
resolution of 50 lm using the ﬂexControl and
ﬂexImaging 2.0 software (Bruker Daltonics). The
number of laser irradiations was 200 shots at each
location, and ion image reconstruction was performed
with ﬂexImaging 2.0 software. The structures of the side
chains of the glycerophospholipid species with one or
two radial side chains are indicated within parentheses
in the following format: head group (coupling scheme-
sn-1/sn-2); e.g., PC (diacyl-16:0/18:1). Signal intensity
was represented for each PC species as relative
intensity to the most abundant signal, PC (diacyl-16:0/
18:1) in the control group.Immunohistochemistry
Frozen sections of the spinal cord were ﬁxed with 2%
paraformaldehyde for 15 min at room temperature. For
the immunoﬂuorescence labeling experiment, spinal
cord sections were ﬁrst blocked in PBS containing 1%
bovine serum albumin, 2% blocking reagent (Roche,
Basel, Schweiz), and 0.1% Triton X-100 for 60 min.
Rabbit anti-NeuN antibody (1:500 Millipore, Billerica,
MA, USA) and rabbit anti-Hb9/HLXB9 (1:250 Abcam,
Cambridge, MA, USA) were incubated at 4 C overnight.
The sections were then incubated with secondary
antibody conjugated with Alexa Fluor 488 donkey anti-
rabbit IgG (Life Technologies, Carlsbad, CA, USA) for
1 h at room temperature. Slides were then washed and
cover slips were mounted onto the slides using a
solution of VECTASHIELD Mounting Medium
(Funakoshi, Tokyo, Japan). All images were obtained
using a scanner (NanoZoomer 2.0HT, Hamamatsu
Photonics, Shizuoka, Japan) or a ﬂuorescent
microscope (AX-80, Olympus, Tokyo, Japan). We
quantiﬁed the expression of Hb9, in cells with the area
larger than 450 lm2 in the anterior horn at various
disease stages in SOD1G93A and control group (n= 3for each group). Analysis was performed using NDP
view software (Hamamatsu Photonics).Statistical analysis
All values are expressed as mean ± SEM. Diﬀerences
between groups were examined about statistical
signiﬁcance using the unpaired two-sample t-test or a
one-way ANOVA test. Post-ANOVA comparisons were
made using the Tukey test. P< 0.05 was considered
as signiﬁcant. The statistical analyses were performed
using the Statistical Package for the Social Sciences
(SPSS) software (version 21.0; SPSS, Chicago, IL,
USA).RESULTS
Characteristics of PC species in the L5 spinal cord of
ALS mice in the terminal stage
To monitor disease progression, body weights of
SOD1G93A mice were measured once a week. Weight
gain diminished by 10 weeks after birth, and body
weight loss began 17 weeks after birth. We began to
observe signiﬁcant diﬀerences in body weight between
SOD1G93A and control mice 10 weeks after birth (Data
not shown). SOD1G93A mice began to die at
approximately 23 weeks of age, and all SOD1G93A mice
died within 25 weeks, in accordance with previous
studies (Takeuchi et al., 2011; Hirano et al., 2013;
Kobayashi et al., 2013).
Given that in SOD1G93A mice, declines in motor
function commence at around 9 weeks of age (Hirano
et al., 2013), we performed MALDI-IMS analysis of the
proﬁle and distribution of PCs in spinal cord specimens
obtained from mice aged ﬁve (presymptomatic stage),
10 (early stage after onset), and 22 weeks (terminal
stage). MALDI-IMS analysis of the L5 spinal cord sections
revealed characteristic PC distribution patterns with dis-
tinct fatty acid (FA) compositions. Speciﬁcally, we com-
pared average mass spectra of L5 spinal cord sections
in the positive ion detection mode. To evaluate the diﬀer-
ence in composition of PC species, we obtained the aver-
age mass spectrum from the entire spinal cord at L5
which included both gray and white matter, for control
(Fig. 1A) and in SOD1G93A mice (Fig. 1B) at the age of
22 weeks. Relative abundance was determined to the
most abundant signal. We then deﬁned signal intensity
according to the relative abundance to the most abundant
PC signal (diacyl-16:0/18:1) observed in the control mice.
Approximately 150 mass peaks in the range of 700 <m/
z< 880 were detected. Among these peaks, 12 intense
peaks were assigned as PC species based on their
masses and previous reports (Sugiura et al., 2009;
Hanada et al., 2012). The peaks at m/z 770.4, 772.4,
798.4, 820.5, 824.5, 826.5, 844.5, 846.5, 848.5, 870.6,
and 872.6 were identiﬁed as PC (diacyl-16:0/16:1), PC
(diacyl-16:0/16:0), PC (diacyl-16:0/18:1), PC (diacyl-
16:0/20:4), PC (diacyl-18:1/18:1), PC (diacyl-18:0/18:1),
PC (diacyl-16:0/22:6), PC (diacyl-18:1/20:4), PC
AB
Fig. 1. Assignment of characteristic PC species at 22 weeks in control and SOD1G93A mice. A representative mass spectrum was obtained using
MALDI-IMS from L5 axial spinal cord sections. Signal intensity corresponds to the relative abundance to the most abundant signal for PC (diacyl-
16:0/18:1) in the control group (A). We detected approximately 150 mass peaks in them/z range from 700 to 880. Among these peaks, we assigned
11 intense peaks as PC species based on a database search and previous reports. The mean signal intensities of the three PCs are surrounded by
squares; PC (diacyl-16:0/22:6), PC (diacyl-16:0/18:1) and PC (diacyl-16:0/20:4), were lower in the SOD1G93A mouse compared to the control (A, B).
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18:0/22:6), respectively (Fig. 1A, B).Visualization of PC species in L5 spinal cord of ALS
mice in the terminal stage
The spectra in Fig. 1A, B represent qualitative data from
the entire spinal cord section at the level of L5 obtained
from 22-week-old control and SOD1G93A mice. We thenreconstructed 11 ion images of the major PC molecular
species by using the ﬂexImaging 2.0 software in order
to analyze the diﬀerences in PC composition.
Representative image from a single mouse per group is
shown in Fig. 2A, B, which resembled the remaining two
mice. And, we have arranged ion images of PCs with
identical FA compositions at the sn-1 position
horizontally, while those with identical FA compositions
at the sn-2 position are arranged vertically (Fig. 2A, B).
Fig. 2. Distributions of PC species in L5 spinal cords of 22-week-old SOD1G93A and control mice. Ion images of PCs obtained by MALDI-IMS are
shown according to their FA compositions. PCs with identical FA compositions at the sn-1 position are arranged horizontally, while those with
identical FA compositions at the sn-2 position are arranged vertically. Several speciﬁc localizations of PCs were found depending on FA
compositions. PCs containing PUFA such as AA (20:4) and DHA (22:6) showed characteristic patterns. Three DHA-containing PCs [PC (16:0/22:6),
PC (18:0/22:6), and PC (18:1/22:6)] were abundant in the gray matter in SOD1G93A mice and controls. By contrast, these PCs were reduced in the
anterior horn in SOD1G93A compared to control (3A, B red circle). Scale bar=500 lm. For both control and SOD1G93A mouse, n= 3. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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was uniformly distributed over the entire gray matter
region in the control mouse spinal cord (Fig. 2A). In
particular, polyunsaturated fatty acids (PUFA), including
FA 22:6 [docosahexaenoic acid (DHA)]-containing PCs,
showed a selective distribution pattern in gray matter.
Three DHA-containing PCs, PC (diacyl-16:0/22:6), PC
(diacyl-18:0/22:6), and PC (diacyl-18:1/22:6), were
relatively abundant in the gray matter in both control
and SOD1G93A spinal cord sections (Fig. 2A, B).
Expression of these DHA-containing PCs was reduced
in the anterior horn in SOD1G93A (Fig. 2B red circle),
whereas expression of the FA 20:4 [arachidonic acid
(AA)]-containing PCs, PC (diacyl-16:0/20:4), and PC
(diacyl-18:0/20:4) showed no apparent diﬀerences
between control and SOD1G93A mice (Fig. 2A, B). PC
(diacyl-16:0/16:0) was observed speciﬁcally in the dorsal
horn gray matter, and expression was similar between
control and SOD1G93A mice (Fig. 2A, B).PC (diacyl-16:0/22:6) expression was decreased in
the L5 anterior horns of SOD1G93A mice in the
terminal stage
To determine when the reduction of PC (diacyl-16:0/22:6)
level in the anterior horn begins, the same analysis was
performed on sections obtained at diﬀerent stages of
the disease. Analysis using MALDI-IMS showed no
signiﬁcant reductions of PC (diacyl-16:0/22:6)
expression in the anterior horn in the pre-symptomatic
stage (5-week-old) (Fig. 3A, D) and early disease stage
(10-week-old) (Fig. 3B, E). However, we continued to
observe a remarkable decrease in the terminal stage
(22-week-old) (Fig. 3C, F). Next we semi-quantitatively
determined the mean signal intensities of PC(diacyl-16:0/22:6) in the anterior horn in L5 spinal cord
sections obtained from both groups at diﬀerent disease
stages using the MALDI-IMS in the positive ion
detection mode (n= 3 for each case). We observed
that the mean signal intensities corresponding to PC
(diacyl-16:0/22:6) in the anterior horn of 22-week-old
SOD1G93A mice were signiﬁcantly lower than those in
the age-matched control group (Fig. 3G). We also semi-
quantitatively compared the mean signal intensities of
PC (diacyl-18:0/22:6) and PC (diacyl-18:1/22:6) in the
anterior horn using L5 spinal cord sections similarly
obtained from both groups (n= 3 for each group)
(Fig. 3H, I). Although non-signiﬁcant, the mean signal
intensities of these two PCs in the anterior horn tended
to be lower in the SOD1G93A mice than in control mice.
(Fig. 3H, I).Reductions in PC (diacyl-16:0/22:6) were associated
with neuronal loss
To examine reductions in PC (diacyl-16:0/22:6) at the
cellular level, we immunostained spinal cord sections of
22-week-old SOD1G93A mice using diﬀerent cell type-
speciﬁc markers. While PC (diacyl-16:0/22:6) and
NeuN reactivity levels were preserved in the control
(Fig. 4A–D) at this age, SOD1G93A mice exhibited a
reduction of both PC (diacyl-16:0/22:6) and NeuN
reactivity in the anterior horn (Fig. 4E–H). Progressive
motor neuron cell death is a characteristic of ALS.
Motor neuron expression Hb9 was quantiﬁed in 5 (pre-
symptomatic stage) (Fig. 4I, L), 10 (early disease stage)
(Fig. 4J, M), and 22-week-old mice (terminal stage)
(Fig. 4K, N). Large lumbar motor neurons with a cell
body area of P450 lm2 were identiﬁed and included
using Hb9, speciﬁc markers for motor neurons. Thus,
Fig. 3. PC (diacyl-16:0/22:6) expression was decreased in the L5 anterior horns of 22-week-old SOD1G93A mouse. In order to evaluate when the
PC (diacyl-16:0/22:6) expression level was decreased, the same analysis was performed at diﬀerent stages. 5 weeks old is the pre-symptomatic
stage (A, D), 10 weeks old is the early stage after disease onset (B, E) and 22 weeks old is the terminal stage (C, F). There were no signiﬁcant
diﬀerences observed at the pre-symptomatic stage (A, D) or the early stage after disease onset (B, E). However PC (diacyl-16:0/22:6) expression in
SOD1G93A was signiﬁcantly lower than control at the terminal stage (C, F red circle). Next we compared the mean signal intensities of PC (diacyl-
16:0/22:6), PC (diacyl-18:0/22:6) and PC (diacyl-18:1/22:6) in the anterior horn of L5 spinal cord sections obtained from both control and SOD1G93A
at week 5, week 10, and week 22 after birth by using MALDI-IMS in the positive ion detection mode (G–I, n= 3 for every data point). We observed
that the mean signal intensities corresponding to PC (diacyl-16:0/22:6) in the anterior horn in the 22-week-old SOD1G93A mouse group were
signiﬁcantly lower than those in the 22-week-old control group (G). We also semi-quantitatively compared the mean signal intensities of PC (diacyl-
18:0/22:6) and PC (diacyl-18:1/22:6) in the anterior horn of L5 spinal cord sections similarly obtained from both groups (n= 3 for each group) (H, I).
Although non-signiﬁcant, the mean signal intensities of these two PCs in the anterior horn tended to be lower in SOD1G93A mice than in control mice.
(H, I). Scale bar = 200 lm. Error bar represent SEM. Signiﬁcant diﬀerences were conﬁrmed using the criterion of p< 0.05 by an unpaired two-
sample t-test or a one-way ANOVA test. Post-ANOVA comparisons were made using the Tukey test. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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death in ALS were quantiﬁed as performed previously
(Seijﬀers et al., 2014). In control mice, no motor neuron
cell death was observed at all the stages. On the other
hand, we observed a remarkable loss in the number of
motor neurons at the terminal stage of SOD1G93A mice
(Fig. 4L–O). There was no signiﬁcant diﬀerence in the
number of motor neurons in L5 anterior horn between
both groups at pre-symptomatic and early disease
stages (Fig. 4I-J, L-M).PC (diacyl-16:0/16:0) expression was preserved in the
L5 dorsal horns of SOD1G93A mice in the terminal
stage
In evaluating alterations in the levels of PCs in the dorsal
horn, we focused on PC (diacyl-16:0/16:0) expression,
which was speciﬁcally distributed in the dorsal horn.
Analysis using MALDI-IMS showed no signiﬁcant
reduction of PC (diacyl-16:0/16:0) expression in the
dorsal horn in the pre-symptomatic stage (5-week-old)(Fig. 5A, D), the early stage after disease onset
(10-week-old) (Fig. 5B, E), and the terminal stage (22-
week-old) (Fig. 5C, F). Next, we semi-quantitatively
compared the mean signal intensities of PC (diacyl-
16:0/16:0) in dorsal horn L5 spinal cord sections
obtained from both groups at the three time points of
the disease using MALDI-IMS in the positive ion
detection mode (n= 3 for each case). We observed no
signiﬁcant diﬀerences in the mean signal intensities
corresponding to PC (diacyl-16:0/16:0) in the dorsal
horn between groups at all stages (Fig. 5G).DISCUSSION
In this study, we performed MALDI-IMS on lumbar spinal
cord tissue sections from SOD1G93A ALS model mice to
identify PC species that exhibited signiﬁcant changes
associated with ALS in the presymptomatic, early stage
after disease onset, and terminal stages. IMS analysis
of spinal cords showed that average spectra detected in
the mass range of 700 <m/z< 880 were almost same
Fig. 4. Reduced PC (diacyl-16:0/22:6) levels were associated with a reduction of NeuN-positive cells in the L5 spinal cord of 22-week-old SOD1G93A
mice. Upper ﬁgures correspond to control (A–D), and lower ﬁgures correspond to SOD1G93A (E–H). A and E show the distribution of PC (diacyl-16:0/
22:6). B and F show the NeuN-staining results. C and G show representative merged images showing the PC (diacyl-16:0/22:6) distribution and
NeuN-staining. D and H show magniﬁed images of the boxed area in C and G. A reduction of PC (diacyl-16:0/22:6) was found in the site where
NeuN-positive neurons have been lost. I–N show the Hb9-staining results. Large lumbar motor neurons with a cell body area of P450 lm2 were
identiﬁed and stained using Hb9, speciﬁc markers for motor neurons. In control mice, no motor neuron cell death was observed at any stage. On the
other hand, we observed a remarkable loss in the number of motor neuron at the terminal stage in SOD1G93A mice (L–O). There was no signiﬁcant
diﬀerence in the number of motor neurons in L5 anterior horn between both groups at pre-symptomatic and early disease stages (I-J, L-M). Error
bars represent SEMs. Signiﬁcant diﬀerences were conﬁrmed using the criterion of p< 0.05 by an unpaired two-sample t-test or a one-way ANOVA
test. Post-ANOVA comparisons were made using Tukey’s test. A–H; Scale bar=100 lm. I–N; Scale bar=50 lm. ⁄p< 0.05, ⁄⁄p< 0.01.
Fig. 5. PC (diacyl-16:0/16:0) expression was preserved in the L5 dorsal horns of 22 week-old SOD1G93A mouse. Analysis using MALDI-IMS
showed no signiﬁcant reduction of PC (diacyl-16:0/16:0) expression in the dorsal horn in the pre-symptomatic stage (5-week old) (A, D), the early
stage after disease onset (10-week old) (B, E), and the terminal stage (22-week old) (C, F). Next we compared the mean signal intensities of PC
(diacyl-16:0/16:0) in the dorsal horn of L5 spinal cord sections obtained from both control and SOD1G93A at 5, 10, and 22 weeks after birth using
MALDI-IMS in the positive ion detection mode (G, n= 3 for every case). There were no signiﬁcant diﬀerences observed in the mean signal
intensities corresponding to PC (diacyl-16:0/16:0) in the anterior horn between both groups at all stages (G). Scale bar=200 lm. Error bars
represent SEMs. Signiﬁcant diﬀerences were conﬁrmed using the criterion of p< 0.05 by an unpaired two-sample t-test or a one-way ANOVA test.
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(22 weeks) (Fig. 1A, B). Among the observed peaks, 12
were determined to be PC molecular species and werevisualized using special software, ﬂexImaging 2.0
(Fig. 2A, B). Since we used a matrix with potassium
acetate for the PC evaluation, all the PC molecular
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previously reported that PC molecular species observed
at m/z 772.4, PC (diacyl-16:0/16:0, K+ adduct), are
localized in the gray matter region, especially in the
dorsal horn (Landgraf et al., 2009; Hanada et al., 2012;
Sugiura et al., 2012). We found that the expression of
PC (diacyl-16:0/16:0) in the dorsal horn of SOD1G93A
ALS model mice was preserved in the terminal stage
(Fig. 5). The dorsal horn is mainly comprised of sec-
ondary sensory neurons. Therefore, our observation that
PC (diacyl-16:0/16:0) was preserved in this region even
at the terminal stage may indicate that sensory functions
of ALS patients are largely preserved until extremely late
stages of the disease.
In contrast, we found that expression of PC (diacyl-
16:0/22:6), PC (diacyl-18:0/22:6), and PC (diacyl-18:1/
22:6) was lower in the anterior horn of ALS mice at
terminal stages compared to age matched controls
(Fig. 2A, B). Interestingly, these PCs are DHA-
containing and reductions of DHA have been observed
in the spinal cord of ALS patients (Ilieva et al., 2007).
DHA is a major component of neural membrane
phospholipids and has potential role related to memory,
learning, and cognitive processes. Previous reports also
show that administration of DHA leads to an
improvement of learning ability. Additionally, DHA is
involved in signal transduction, neuronal diﬀerentiation,
neurogenesis, and protection against synaptic loss or
spinal cord injury (Arima et al., 2014). These ﬁndings thus
imply that DHA-containing PCs play important roles in the
development, normal physiology, and degeneration of the
nervous system. In a previous report, reduction of DHA-
containing PCs was markedly decreased in the gray mat-
ter of human Alzheimer’s disease brains, which was sig-
niﬁcantly correlated with disease duration (Yuki et al.,
2014). Furthermore, at the molecular level, this depletion
was associated with reduced levels of the postsynaptic
protein PSD-95 but not the presynaptic protein synapto-
physin. Interestingly, this reduction in PC (diacyl-18:0/
22:6) levels did not correlate with the degrees of Ab
deposition and neuronal loss in Alzheimer’s disease
(Yuki et al., 2014). In the anterior horn of our SOD1G93A
ALS model mice, we observed alterations of PC (diacyl-
16:0/22:6), which is also a DHA-containing PCs, in the
terminal, but not earlier disease stage (Fig. 3).
Alterations of DHA-containing PCs were not found in
other gray or white matter regions including the anterior,
lateral, and posterior funiculus. We further conﬁrmed that
the reduction of DHA-containing PCs and of Hb9-positive
motor neurons in the anterior horn occurred simultane-
ously in the ALS terminal stage and they seemed to be
colocalized spatiotemporarily (Figs. 3 and 4). Thus, the
reduction of DHA could be reﬂecting the loss (apoptosis)
of motor neurons themselves in the anterior horn of the
spinal cord in ALS mice. In addition, the reduction of
DHA could be aﬀecting on the motor endplate, leading
to the ‘‘dying back’’ of the motor axons from the neuro-
muscular junction.
As DHA contains six double bonds, it is likely to be
oxidized by free radicals (Schafer et al., 2000; Yuki
et al., 2014). Indeed, a biochemical study hasdemonstrated that lipid peroxidation was enhanced in
spinal cord motor neurons of ALS patients (Shibata
et al., 2001). Therefore, the cause of the compositional
decrease of DHA-containing PCs in the anterior horn of
ALS mouse might be oxidative stress.
Our ﬁndings suggest that reductions of DHA levels
might be important in ALS, while other work suggests
that dietary intake of DHA is eﬀective in regulating brain
DHA levels. Rodent studies have revealed that levels of
DHA-containing phospholipids in the central nervous
system are decreased by depletions of DHA in the diet
(Garcia et al., 1998; Hamilton et al., 2000). Oral supple-
mentation with DHA has been shown to elevate brain
DHA levels in rats (Hashimoto et al., 2002). There are
several reports that omega-3 FA (e.g., DHA) treatment
has neuroprotective eﬀects against central nervous sys-
tem injury and aging (King et al., 2006; Dyall et al.,
2010; Lim et al., 2010). However, the mechanisms under-
lying these therapeutic eﬀects are still poorly understood.
In contrast, it was reported that dietary
supplementation with eicosapentaenoic acid (20:5,
EPA), which is converted to DHA in vivo, increased the
numbers of activated microglia and astrocytes in the
brain of an ALS mouse model (Yip et al., 2013).
Moreover, treatment with EPA initiated at the pre-symp-
tomatic stage led to a signiﬁcantly shorter lifespan (Yip
et al., 2013). The authors thus concluded that dietary
EPA supplementation in ALS patients was not eﬀective,
but rather harmful. Taking these ﬁndings into considera-
tion, the decrease of DHA-containing PCs in the anterior
horn of ALS mice observed in this study was unlikely to
be a cause of disease progression, but rather may have
been a reﬂection of it.
In the future, we must clarify the cause of the
decrease of DHA-containing PCs in the anterior horn of
ALS model mice and the role of DHA-containing PCs in
neuronal cells in more detail. Further elucidating the
characteristics and biological roles of DHA containing
PCs in ALS is expected to be useful in the prevention of
ALS and the development of therapeutic agents for
ALS. Moreover, pathological studies have shown that
the cranial motor nuclei of the oculomotor, trochlear,
and abducens nerves, and Onuf’s nucleus in the sacral
spinal cord are relatively spared in human ALS (Mannen
et al., 1977; Okamoto et al., 1993; Brockington et al.,
2013). Therefore, analysis of such DHA-containing lipids
in these neurons and their comparison with those in the
anterior horn of spinal cord at the level of L5 can provide
valuable insights about pathology of this disease.
CONCLUSION
Our data revealed a signiﬁcant decrease in DHA-
containing PCs in the anterior horn of the spinal cord of
ALS mice in the terminal stage, which may reﬂect
neuronal loss. These ﬁndings indicate that ALS spinal
cords may show signiﬁcant alterations in PC metabolism
present only in the terminal stage of the disease.
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